Protective effects of farrerol against hydrogen-peroxide-induced apoptosis in human endothelium-derived EA.hy926 cells

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 9, 2013, Pages 733-740

  Li, Jian Kuan ^a   Ge, Rui ^a   Tang, Li ^a   Li, Qing Shan ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; EA.hy926 cells; Farrerol; Hydrogen peroxide; Oxidative stress

Indexed keywords

CASPASE 3; FARREROL; FLAVONOID; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MALONALDEHYDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CHINESE HERB; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE EXPRESSION; HEART PROTECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CELL SURVIVAL; CHROMONES; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 84883276417     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2013-0008     Document Type: Article

References (42)

1. Adams, J.M., and Cory, S. 1998. The Bcl-2 protein family: arbiters of cell survival. Science, 281(5381): 1322-1326. doi:10.1126/science.281.5381.1322.
2. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X.D. 1999. Biochemical pathway of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15: 269-290. doi:10.1146/annurev.cellbio.15.1.269.
3. Chen, T., Guo, Z., Jiao, X., Zhang, Y., Li, J., and Liu, H. 2011. Protective effects of peoniflorin against hydrogen peroxide-induced oxidative stress in human umbilical vein endothelial cells. Can. J. Physiol. Pharmacol. 89(6): 445-453. doi:10.1139/y11-034.
4. Cho, J. 2006. Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperitin. Arch. Pharm. Res. 29(8): 699-706. doi:10.1007/BF02968255.
5. Choy, J.C., Granville, D.J., Hunt, D.W.C., and McManus, B.M. 2001. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J. Mol. Cell. Cardiol. 33(9): 1673-1690. doi:10.1006/jmcc.2001.
6. Ci, X.X., Chu, X., Wei, M.M., Yang, X.F., Cai, Q.R., and Deng, X.M. 2012. Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injury. PLoS One, 7(4): e34634. doi:10.1371/journal.pone.0034634.
7. Daniele, V., Elena, D., Agostino, V., Lorenzo, G., and Stefano, T. 2009. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care, 32(Suppl. 2): S314-S321. doi:10.2337/dc09-s330.
8. Deanfield, J.E., Halcox, J.P., and Rabelink, T.J. 2007. Endothelial function and dysfunction:testing and clinical relevance. Circulation, 115(10): 1285-1295. doi:10.1161/CIRCULATIONAHA.106.652859.
9. Diane, B., Geke, A.P.H., Coby, M., Grietje, M., and Nanno, M. 2001. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vesselrelated research. Angiogenesis, 4(2): 91-102. doi:10.1023/A:1012259529167.
10. Dimmeler, S., Hermann, C., and Zeiher, A.M. 1998. Apoptosis of endothelial cells: contribution to the pathophysiology of atherosclerosis. Eur. Cytokine Netw. 9(4): 697-698.
11. Edgell, C.J., McDonald, C.C., and Graham, J.B. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A. 80(12): 3734-3737. doi:10.1073/pnas.80.12.3734.
12. Edgell, C.J.S., Haizlip, J.E., Bagnell, C.R., Packenham, J.P., Harrison, P., Wilbourn, B., et al. 1990. Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell. Dev. Biol. 26(12): 1167-1172. doi:10.1007/BF02623694.
13. Feng, Y.S., and Zhu, D.Z. 1979. Metabolism of farrerol. Acta Pharmaceutical Sinica, 14(3): 149-155.
14. Gawel, S., Wardas, M., Niedworok, E., and Wardas, P. 2004. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad. Lek. 57(9-10): 453-455.
15. Guyton, K.Z., Liu, Y., Gorospe, M., Xu, Q., and Holbrook, N.J. 1996. Activation of mitogen-activated protein kinase by H2O2: role in cell survival following oxidative injury. J. Biol. Chem. 271(8): 4138-4142. doi:10.1074/jbc.271.8.4138.
16. Haller, H. 1997. Endothelial function: general considerations. Drugs, 53(Suppl. 1): 1-10. doi:10.2165/00003495-199700531-00003.
17. Hwang, S.L., and Yen, G.C. 2008. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 Cells. J. Agric. Food Chem. 56(3): 859-864. doi:10.1021/jf072826r.
18. Incani, A., Deiana, M., Corona, G., Vafeiadou, K., Vauzour, D., Dessi, M.A., et al. 2010. Involvement of ERK, Akt and JNK signaling in H2O2-induced cell injury and protection by hydroxytyrosol and its metabolite homovanillic alcohol. Mol. Nutr. Food Res. 54(6): 788-796. doi:10.1002/mnfr.200900098.
19. Jeong, Y.J., Choi, Y.J., Kwon, H.M., Kang, S.W., Park, H.S., Lee, M., et al. 2005. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br. J. Nutr. 93(5): 581-591. doi:10. 1079/BJN20041397.
20. Jia, L.Q., Yang, G.L., Ren, L., Chen, W.N., Feng, J.Y., Cao, Y., et al. 2012. Tanshinone IIA reduces apoptosis induced by hydrogen peroxide in the human endothelium-derived EA.hy926 cells. J. Ethnopharmacol. 143(1): 100-108. doi: 10.1016/j.jep.2012.06.007.
21. Jin, J., Zhu, J.F., Yaoo, X.J., and Wu, L.M. 2007. Study on the binding of farrerol to human serum albumin. J. Photochem. Photobiol. A Chem. 191(1): 59-65. doi:10.1016/j.jphotochem.2007.04.004.
22. Li, Q.Y., Chen, L., Zhu, Y.H., Zhang, M., Wang, Y.P., and Wang, M.W. 2011. Involvement of estrogen receptor-_ in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation. Acta Pharmacol. Sin. 32(4): 433-440. doi:10.1038/aps.2011.1.
23. Liu, B.M., Jian, Z., Li, Q., Li, K., Wang, Z.Y., Liu, L., et al. 2012. Baicalein protects human melanocytes from H2O2-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway. Free Radic. Biol. Med. 53(2): 183-193. doi:10.1016/j.freeradbiomed.2012.04.015.
24. Lykkesfeldt, J. 2007. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin. Chim. Acta, 380(1-2): 50-58. doi:10.1016/j.cca. 2007.01.028.
25. Michiels, C., Raes, M., Toussaint, O., and Remacle, J. 1994. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17(3): 235-248. doi:10.1016/0891-5849(94)90079-5.
26. Middleton, E., Jr., Kandaswami, C., and Theoharides, T.C. 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52(4): 673-751.
27. Nijveldt, R.J., van Nood, E., van Hoorn, D.E.C., Boelens, P.G., van Nooren, K., and van Leeuwen, P.A.M. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74(4): 418-425.
28. Qiu, J.Z., Xiang, H., Hu, C., Wang, Q., Dong, J., Li, H.E., et al. 2011. Subinhibitory concentrations of farrerol reduce α-toxin expression in Staphylococcus aureus, FEMS Microbiol. Lett. 315(2): 129-133. doi:10.1111/j.1574-6968.2010.02183.x.
29. Riedl, S.J., and Shi, Y.G. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5(11): 897-907. doi:10.1038/nrm1496.
30. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340(2): 115-126. doi:10.1056/NEJM199901143400207.
31. Runchel, C., Matsuzawa, A., and Ichijo, H. 2011. Mitogen-activated protein kinases in mammalian oxidative stress responses. Antioxid. Redox Signal. 15(1): 205-218. doi:10.1089/ars.2010.3733.
32. Teillet, F., Boumendjel, A., Boutonnat, J., and Ronot, X. 2008. Flavonoids as RTK inhibitors andprotential anticancer agents. Med. Res. Rev. 28(5): 715-745. doi:10.1002/med.20122.
33. Tim, M. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1-2): 55-63. doi:10.1016/0022-1759(83)90303-4.
34. Triggle, C.R., Samuel, S.M., Ravishankar, S., Marei, I., Arunachalam, G., and Ding, H. 2012. The endothelium: influencing vascular smooth muscle in many ways. Can. J. Physiol. Pharmacol. 90(6): 713-738. doi:10.1139/y2012-073.
35. Trivedi, P.P., Kushwaha, S., Tripathi, D.N., and Jena, G.B. 2011. Cardioprotective effect of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc. Toxicol. 11(3): 215-225. doi:10.1007/s12012-011-9114-2.
36. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270(5240): 1326-1331. doi:10.1126/science.270.5240.1326.
37. Xiao, P.G. 2001. New edition of traditional Chinese medicines record. Chemical Industry Publisher, Beijing, China. pp. 515-516.
38. Youle, R.J., and Strasser, A. 2008. The Bcl-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9(1): 47-59. doi:10.1038/nrm2308.
39. Zhang, G.D., Wang, M.Z., and Zhang, S.R. 1980. Studies on the quantitative determination of farrerol in Man-shan-hong (Rhododendron Dauricum T.) leaves. Acta Pharmacol. Sin. 15(12): 736-740.
40. Zhang, G.W., Wang, L., Fu, P., and Hu, M.M. 2011a. Mechanism and conformational studies of farrerol binding to bovine serum albumin by spectroscopic methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 82(1): 424-431. doi:10.1016/j.saa.2011.07.073.
41. Zhang, G.W., Fu, P., Wang, L., and Hu, M.M. 2011b. Molecular spectroscopic studies of farrerol interaction with calf thymus DNA. J. Agric. Food Chem. 59(16): 8944-8952. doi:10.1021/jf2019006.
42. Zhu, J.F., Li, D.J., Jin, J., and Wu, L.M. 2007. Binding analysis of farrerol to lysozyme by spectroscopic methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 68(2): 354-359. doi:10.1016/j.saa.2006.11.045.